×

Device, systems and methods for evaluation of hemostasis

  • US 9,272,280 B2
  • Filed: 02/15/2012
  • Issued: 03/01/2016
  • Est. Priority Date: 02/15/2011
  • Status: Expired due to Fees
First Claim
Patent Images

1. A device for evaluation of hemostasis, comprising:

  • a plurality of test chambers each configured to receive blood of a test sample, each test chamber comprising a reagent or combination of reagents, wherein each chamber is configured to be interrogated to determine a hemostatic parameter of the blood received therein;

    a first chamber of the plurality comprising a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is an activator of coagulation; and

    a second chamber of the plurality comprising a second combination of reagents that interact with blood of the test sample received therein, the combination including an activator of coagulation and one or both of abciximab and cytochalasin D.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×